Traditional Chinese Medicine for Treatment of Chronic Heart Failure
NCT01939236 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2013-10-10
Summary
The purpose of this study is to determine whether traditional Chinese medicine as complementary treatment is safe and effective in the treatment of chronic heart failure.
Conditions
Interventions
- DRUG
-
traditional Chinese medicine
1 bag of drug 2 times per day for 28 days according to syndrome differentiation. For example, the syndrome of one patient is qi deficiency and blood stasis, he will take drugs of qi deficiency and blood stasis each bag 2 times per day for 28days.
- DRUG
-
Placebo (gummeline)
Placebo of each syndrome differentiation has the same weight and smell as traditional Chinese medicine of corresponding syndrome differentiation. 1 bag of drug 2 times per day for 28 days according to syndrome differentiation. For example, the syndrome of one patient is qi deficiency and blood stasis, he will take drugs of qi deficiency and blood stasis each bag 2 times per day for 28 days.
Sponsors & Collaborators
-
Wuhan Hospital of Traditional Chinese Medicine
collaborator OTHER -
Zhengzhou Hospital of Traditional Chinese Medicine
collaborator OTHER -
Changchun University of Chinese Medicine
collaborator OTHER -
Hubei Hospital of Traditional Chinese Medicine
collaborator OTHER -
Yichang Hospital of Traditional Chinese Medicine
collaborator OTHER -
Dongzhimen Hospital, Beijing
collaborator OTHER -
Guang'an Men Hospital Affiliated to China Academy of Chinese Medicine Sciences
collaborator UNKNOWN -
Beijing University of Chinese Medicine
lead OTHER
Principal Investigators
-
Wei Wang, Doctor · Beijing University of Chinese Medicine
-
Peng Zhang, Doctor · Wuhan Hospital of Chinese Medicine
-
Huihui Zhao, Doctor · Beijing University of Chinese Medicine
-
Liangtao Luo, Master · Beijing University of Chinese Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2012-08-31
- Completion
- 2012-09-30
Countries
- China
Study Locations
More Related Trials
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia
NCT03185923 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Yiqi Fuyuan Paste Formula in Chronic Fatigue Syndrome: A Randomized Double-Blind Controlled Clinical Trial.
NCT07320937 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment
NCT07041359 ·Status: RECRUITING ·Phase: PHASE4
-
Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat
NCT01612260 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction
NCT04695990 ·Status: UNKNOWN ·Phase: PHASE2
-
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
NCT06452966 ·Status: RECRUITING ·Phase: NA
-
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
NCT00965471 ·Status: COMPLETED ·Phase: NA
-
The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula
NCT06686355 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Traditional Chinese Medicine of Severe COVID-19
NCT06714032 ·Status: COMPLETED ·Phase: PHASE3
-
Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study
NCT07088523 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
NCT01053533 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency
NCT04317339 ·Status: UNKNOWN ·Phase: PHASE2
-
The Relationship Between XinKang-I and Chronic Heart Failure
NCT05847959 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality
NCT03018769 ·Status: UNKNOWN
-
Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms
NCT01844050 ·Status: COMPLETED ·Phase: NA
-
Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia
NCT01613183 ·Status: UNKNOWN ·Phase: NA
-
Study on Therapeutic Effect of Treating Mental Stress Induced Myocardial Ischemia
NCT02135250 ·Status: UNKNOWN ·Phase: NA
-
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
NCT04251871 ·Status: UNKNOWN ·Phase: NA
-
A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Characteristics.
NCT06095258 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
NCT06373692 ·Status: NOT_YET_RECRUITING
-
Acupuncture on Cardiac and Autonomic Function in Human Heart Failure
NCT01804816 ·Status: COMPLETED ·Phase: NA
-
Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)
NCT00817024 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
NCT04022031 ·Status: UNKNOWN
-
The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine
NCT01677325 ·Status: COMPLETED ·Phase: PHASE1